A
Atea Pharmaceuticals (AVIR)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Atea Pharmaceuticals (AVIR)
Atea Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing antiviral therapeutics to improve the lives of patients suffering from life-threatening viral infections.... Read more
- USD3.65
- USD3.75
- USD3.65
- USD4.15
- 14.50%
- --
- 349.88k
- 410.34k
- 320M
- 2.46
- 12.00%
Stock News
5 hours ago
Best Stock to Buy Right Now: Uber vs. Tesla
Yahoo
yesterday
Social Security touts customer-service milestones, but some say it’s ‘cherry picking’ performance improvements
MarketWatch
yesterday
TSA plans to let travelers keep their shoes on at airport security checkpoints
CNBC
yesterday
Here are winners and losers of Tuesday's stealth market rotation — plus, Nvidia $4T watch
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
